Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent
14. Oktober 2024 06:00 ET
|
Ardena Holding NV.
Ardena acquires Catalent's Somerset, NJ facility, expanding its US presence and boosting advanced oral drug product manufacturing capabilities.
Kuehn Law Encourages NGM, CTLT, SDPI, and HRT Investors to Contact Law Firm
22. März 2024 13:34 ET
|
KUEHN LAW, PLLC
Kuehn Law investigates potential claims related to proposed mergers of NGM, CTLT, SDPI, and HRT. Shareholders urged to contact for more info.
CTLT Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Catalent, Inc. for Potential Securities Law Violations
07. Februar 2024 09:13 ET
|
Wohl & Fruchter LLP
MONSEY, N.Y., Feb. 07, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Catalent, Inc. (NYSE: CTLT) (“Catalent”) has violated federal securities laws based...
Kuehn Law Encourages ZFOX, CTLT, SLAM, and EVBG Investors to Contact Law Firm
06. Februar 2024 11:13 ET
|
KUEHN LAW, PLLC
NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...
CTLT Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Catalent to Novo Holdings
05. Februar 2024 10:04 ET
|
Wohl & Fruchter LLP
We are investigating the fairness of the sale of Catalent to Novo Holdings for $63.50 per share in cash.
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
27. September 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Catalent, Inc. (NYSE:...
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
21. August 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Catalent, Inc. (NYSE:...
Regeneron Pharmaceuticals Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
25. Juli 2023 15:04 ET
|
Block & Leviton LLP
BOSTON, July 25, 2023 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) for potential securities law violations. Investors who have lost money...
Strong Growth Projected for Biologics CDMO Market with a CAGR of 11.8% during 2022-2032, Fueled by Technological Advancements in Bioprocessing - BY PMI
14. Juni 2023 12:30 ET
|
PMI
Covina, June 14, 2023 (GLOBE NEWSWIRE) -- What is Biologics CDMO? How big is the Biologics CDMO Market? Report Overview: Biologics are group of medicines which includes, immune modulators,...
CTLT FINAL DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important April 25 Deadline in Securities Class Action – CTLT
22. April 2023 12:35 ET
|
The Rosen Law Firm PA
NEW YORK, April 22, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Catalent, Inc. (NYSE: CTLT) between August 30, 2021 and...